Innate immune dysfunction in acute and chronic liver disease

Wiener Klinische Wochenschrift

Volumn 121, Issue 23-24, 2009, Pages 732-744

  Leber, Bettina ^a   Mayrhauser, Ursula ^a   Rybczynski, Michael ^a   Stadlbauer, Vanessa ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acute liver failure; Acute on chronic liver failure; Albumin; Cirrhosis; Endotoxin; Gut permeability; Immune dysfunction; Infection; Monocyte; Neutrophil; Toll like receptors

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; COLONY STIMULATING FACTOR; ENDOTOXIN; LIPOPROTEIN; PROBIOTIC AGENT; TOLL LIKE RECEPTOR;

ALBUMIN DIALYSIS; ANTIBIOTIC PROPHYLAXIS; CELL FUNCTION; DIET THERAPY; DRUG MECHANISM; HEPATIC ENCEPHALOPATHY; HOSPITAL INFECTION; HUMAN; IMMUNOPATHOLOGY; INFECTION RISK; INNATE IMMUNITY; KUPFFER CELL; LIVER CIRRHOSIS; LIVER SUPPORT; LIVER TRANSPLANTATION; MONOCYTE; NEUTROPHIL; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; REVIEW;

ACUTE DISEASE; CHRONIC DISEASE; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, INNATE; LIVER DISEASES;

EID: 77249171827     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-009-1288-2     Document Type: Review

References (151)

1. DA Leon J McCambridge 2006 Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data Lancet 367 52 56 16399153
2. L Kazemi-Shirazi MP Veloso F Frommlet P Steindl-Munda F Wrba S Zehetmayer, et al. 2008 Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful? Wien Klin Wochenschr 120 25 30 1:CAS:528:DC%2BD1cXntFaqurw%3D 18239988
3. A Mansour W Watson V Shayani J Pickleman 1997 Abdominal operations in patients with cirrhosis: still a major surgical challenge Surgery 122 730 735 1:STN:280:DyaK1c%2FgslGguw%3D%3D 9347849 discussion 735-736
4. Vital and Health Statistics Series 13 N
5. G Ostapowicz WM Lee 2000 Acute hepatic failure: a Western perspective J Gastroenterol Hepatol 15 480 488 1:STN:280:DC%2BD3cvotV2jug%3D%3D 10847432
6. GR Bond JE Novak 1995 The human and economic cost of paracetamol (acetaminophen) overdose Pharmaco-economics 8 177 181 1:STN:280: DyaK28%2FmtlCksw%3D%3D
7. A Aggarwal JP Ong ZM Younossi DR Nelson L Hoffman-Hogg AC Arroliga 2001 Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU Chest 119 1489 1497 1:STN:280:DC%2BD3MvhtVGltw%3D%3D 11348958
8. M Navasa J Fernandez J Rodes 1999 Bacterial infections in liver cirrhosis Ital J Gastroenterol Hepatol 31 616 625 1:STN:280:DC%2BD3c%2FntFOksQ%3D%3D 10604106
9. WR Caly E Strauss 1993 A prospective study of bacterial infections in patients with cirrhosis J Hepatol 18 353 358 1:STN:280:DyaK2c%2FksVKhtQ%3D%3D 8228129
10. G Linderoth P Jepsen HC Schonheyder SP Johnsen HT Sorensen 2006 Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: a population-based cohort study Alcohol Clin Exp Res 30 636 641 16573581
11. R Jalan R Williams 2002 Acute-on-chronic liver failure: pathophysiological basis of therapeutic options Blood Purif 20 252 261 11867872
12. G D'Amico A Morabito L Pagliaro E Marubini 1986 Survival and prognostic indicators in compensated and decompensated cirrhosis Dig Dis Sci 31 468 475 3009109
13. TI Huo HC Lin JC Wu FY Lee MC Hou PC Lee, et al. 2006 Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis Liver Transpl 12 65 71 16382473
14. G Goldfarb O Nouel T Poynard B Rueff 1983 Efficiency of respiratory assistance in cirrhotic patients with liver failure Intensive Care Med 9 271 273 1:STN:280:DyaL2c%2FgvVOktw%3D%3D 6619394
15. RG Shellman WJ Fulkerson E DeLong CA Piantadosi 1988 Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit Crit Care Med 16 671 678 1:STN:280:DyaL1c3isVaktg%3D%3D 3371043
16. CA Zauner RC Apsner A Kranz L Kramer C Madl B Schneider, et al. 1996 Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoring systems Intensive Care Med 22 559 563 1:STN:280:DyaK28vgvFCruw%3D%3D 8814471
17. JE Zimmerman DP Wagner MG Seneff RB Becker X Sun WA Knaus 1996 Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival Hepatology 23 1393 1401 1:STN:280: DyaK283ktlWmug%3D%3D 8675156
18. KC Lee AA Chiang 1997 The outcome of terminal liver cirrhosis patients requiring mechanical ventilation Zhonghua Yi Xue Za Zhi (Taipei) 59 88 94 1:STN:280:DyaK2szhvVeksg%3D%3D
19. N Singh T Gayowski MM Wagener IR Marino 1998 Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality J Gastroenterol 33 73 79 1:STN:280:DyaK1c7ls12mtQ%3D%3D 9497225
20. JP Kress A Rubin AS Pohlman JB Hall 2000 Outcomes of critically ill patients denied consideration for liver transplantation Am J Respir Crit Care Med 162 418 423 1:STN:280:DC%2BD3cvjtlCjtw%3D%3D 10934063
21. M Wehler J Kokoska U Reulbach EG Hahn R Strauss 2001 Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems Hepatology 34 255 261 1:STN:280:DC%2BD3MvjtlCksg%3D%3D 11481609
22. MH Tsai YC Chen YP Ho JT Fang JM Lien CT Chiu, et al. 2003 Organ system failure scoring system can predict hospital mortality in critically ill cirrhotic patients J Clin Gastroenterol 37 251 257 12960725
23. MH Tsai YS Peng JM Lien HH Weng YP Ho C Yang, et al. 2004 Multiple organ system failure in critically ill cirrhotic patients. A comparison of two multiple organ dysfunction/failure scoring systems Digestion 69 190 200 15178929 (Pubitemid 38813029)
24. YC Chen MH Tsai YP Ho CW Hsu HH Lin JT Fang, et al. 2004 Comparison of the severity of illness scoring systems for critically ill cirrhotic patients with renal failure Clin Nephrol 61 111 118 1:STN:280:DC%2BD2c%2FpvFCkug%3D%3D 14989630
25. YC Chen MH Tsai CW Hsu YP Ho JM Lien MY Chang, et al. 2003 Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding J Nephrol 16 558 565 14696759
26. YP Ho YC Chen C Yang JM Lien YY Chu JT Fang, et al. 2004 Outcome prediction for critically ill cirrhotic patients: a comparison of APACHE II and Child-Pugh scoring systems J Intensive Care Med 19 105 110 15070520 (Pubitemid 44526575)
27. TR Gildea WC Cook DR Nelson A Aggarwal W Carey ZM Younossi, et al. 2004 Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU Chest 126 1598 1603 15539733
28. E Cholongitas M Senzolo D Patch K Kwong V Nikolopoulou G Leandro, et al. 2006 Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit Aliment Pharmacol Ther 23 883 893 1:STN:280:DC%2BD287nvFKksQ%3D%3D 16573791
29. E Cholongitas GV Papatheodoridis M Vangeli N Terreni D Patch AK Burroughs 2005 Systematic review: The model for end-stage liver disease - should it replace Child-Pugh classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 22 1079 1089 1:STN:280:DC%2BD2MnisVKguw%3D%3D 16305721
30. D du Cheyron B Bouchet JJ Parienti M Ramakers P Charbonneau 2005 The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis Intensive Care Med 31 1693 1699 16244877 (Pubitemid 41677246)
31. L Kramer 2004 Acute liver failure Wien Klin Wochenschr 116 67 81 1:CAS:528:DC%2BD2cXjtl2gtLg%3D 15008314
32. LE Schmidt FS Larsen 2006 Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure Crit Care Med 34 337 343 16424712
33. CG Antoniades PA Berry ET Davies M Hussain W Bernal D Vergani, et al. 2006 Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure Hepatology 44 34 43 1:CAS:528:DC%2BD28XnsFWjtrk%3D 16799971
34. J Wade N Rolando J Philpott-Howard J Wendon 2003 Timing and aetiology of bacterial infections in a liver intensive care unit J Hosp Infect 53 144 146 1:STN:280:DC%2BD3s%2FnsFymtw%3D%3D 12586576
35. N Rolando A Gimson J Wade J Philpott-Howard M Casewell R Williams 1993 Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure Hepatology 17 196 201 1:STN:280: DyaK3s7lsVKltg%3D%3D 8428715
36. J Vaquero J Polson C Chung I Helenowski FV Schiodt J Reisch, et al. 2003 Infection and the progression of hepatic encephalopathy in acute liver failure Gastroenterology 125 755 764 12949721 (Pubitemid 37070693)
37. IN Hines MD Wheeler 2004 Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis Am J Physiol Gastrointest Liver Physiol 287 G310 G314 1:CAS:528:DC%2BD2cXmvVKntbs%3D 15246965
38. CG Antoniades PA Berry JA Wendon D Vergani 2008 The importance of immune dysfunction in determining outcome in acute liver failure J Hepatol 49 845 861 1:CAS:528:DC%2BD1cXht1eisr7M 18801592
39. WI Jeong B Gao 2008 Innate immunity and alcoholic liver fibrosis J Gastroenterol Hepatol 23 Suppl 1 S112 S118 1:CAS:528:DC%2BD1cXkslKgt7w%3D 18336653
40. G Baffy 2009 Kupffer cells in non-alcoholic fatty liver disease: the emerging view J Hepatol 51 212 223 1:CAS:528:DC%2BD1MXntVKgu74%3D 19447517
41. U Thalheimer CK Triantos DN Samonakis D Patch AK Burroughs 2005 Infection, coagulation, and variceal bleeding in cirrhosis Gut 54 556 563 1:CAS:528:DC%2BD2MXjtFams7w%3D 15753544
42. A Rimola R Soto F Bory V Arroyo C Piera J Rodes 1984 Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis Hepatology 4 53 58 1:STN:280:DyaL2c7htVShsA%3D%3D 6693068
43. M Ueno 1990 Endotoxemia and its compensatory mechanisms in experimental liver cirrhosis Nippon Shokakibyo Gakkai Zasshi 87 1692 1700 1:CAS:528:DyaK3MXhsVSrtrg%3D 2232302
44. E Abdala CES Baia S Mies PCB Massarollo NP Cavalheiro VRM Baia, et al. 2007 Bacterial translocation during liver transplantation: A randomized trial comparing conventional with venovenous bypass vs. piggyback methods Liver Transplantation 13 488 496 17436334
45. M von Frankenberg M Golling A Mehrabi H Nentwich E Klar TW Kraus 2003 Donor pretreatment with gadolinium chloride improves early graft function and survival after porcine liver transplantation Transpl Int 16 806 813 1:CAS:528:DC%2BD3sXptFahtrk%3D 12879229
46. H Jaeschke T Hasegawa 2006 Role of neutrophils in acute inflammatory liver injury Liver Int 26 912 919 1:CAS:528:DC%2BD28XhtF2qsbzI 16953830 (Pubitemid 44323408)
47. AM Condliffe E Kitchen ER Chilvers 1998 Neutrophil priming: pathophysiological consequences and underlying mechanisms Clin Sci (Lond) 94 461 471 1:CAS:528:DyaK1cXjslGlsb4%3D
48. J Taieb P Mathurin C Elbim P Cluzel M Arce-Vicioso B Bernard, et al. 2000 Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids J Hepatol 32 579 586 1:CAS:528:DC%2BD3cXisFOjsbY%3D 10782906
49. AJ Stanley IR MacGregor JF Dillon IA Bouchier PC Hayes 1996 Neutrophil activation in chronic liver disease Eur J Gastroenterol Hepatol 8 135 138 1:STN:280:DyaK28zgvFWgsQ%3D%3D 8723417
50. E Feliu MA Gougerot J Hakim E Cramer C Auclair B Rueff, et al. 1977 Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis Eur J Clin Invest 7 571 577 1:CAS:528:DyaE1cXhvVOmsro%3D 415878
51. IA Rajkovic R Williams 1985 Mechanisms of abnormalities in host defences against bacterial infection in liver disease Clin Sci (Lond) 68 247 253 1:STN:280:DyaL2M7isFKntA%3D%3D
52. C Fiuza M Salcedo G Clemente JM Tellado 2000 In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease J Infect Dis 182 526 533 1:STN:280:DC%2BD3cvlvFShtA%3D%3D 10915084
53. R Kirsch VE Woodburne EG Shephard RE Kirsch 2000 Patients with stable uncomplicated cirrhosis have normal neutrophil function J Gastroenterol Hepatol 15 1298 1306 1:STN:280:DC%2BD3M7gsVyltA%3D%3D 11129225
54. A Parlesak C Schafer SB Paulus S Hammes JP Diedrich C Bode 2003 Phagocytosis and production of reactive oxygen species by peripheral blood phagocytes in patients with different stages of alcohol-induced liver disease: effect of acute exposure to low ethanol concentrations Alcohol Clin Exp Res 27 503 508 1:CAS:528:DC%2BD3sXitlKitbY%3D 12658117
55. H Neugebauer P Hartmann S Krenn T Gluck J Scholmerich R Straub, et al. 2008 Bacterial translocation increases phagocytic activity of polymorphonuclear leucocytes in portal hypertension: priming independent of liver cirrhosis Liver Int 28 1149 1157 18662280
56. RP Mookerjee V Stadlbauer S Lidder GA Wright SJ Hodges NA Davies, et al. 2007 Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome Hepatology 46 831 840 1:CAS:528: DC%2BD2sXhtFWhsrvJ 17680644
57. R Urbaschek RS McCuskey V Rudi KP Becker F Stickel B Urbaschek, et al. 2001 Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease Alcohol Clin Exp Res 25 261 268 1:CAS:528:DC%2BD3MXhsVyltb4%3D 11236841
58. EE Etheredge JA Spitzer 1993 Chronic endotoxemia reversibly alters respiratory burst activity of circulating neutrophils J Surg Res 55 261 268 1:STN:280:DyaK2c%2FhslKquw%3D%3D 8412108
59. RH Bohmer LS Trinkle JL Staneck 1992 Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst Cytometry 13 525 531 1:CAS:528:DyaK38Xls12jt7o%3D 1321708
60. HE Wasmuth D Kunz E Yagmur A Timmer-Stranghoner D Vidacek E Siewert, et al. 2005 Patients with acute on chronic liver failure display "sepsis-like" immune paralysis J Hepatol 42 195 201 1:CAS:528:DC%2BD2MXmvFSqug%3D%3D 15664244
61. T Xing L Li H Cao J Huang 2007 Altered immune function of monocytes in different stages of patients with acute on chronic liver failure Clin Exp Immunol 147 184 188 1:CAS:528:DC%2BD2sXhtVCrsrs%3D 17177978
62. ML Berres B Schnyder E Yagmur B Inglis S Stanzel JJ Tischendorf, et al. 2009 Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis Liver Int 29 536 543 1:CAS:528:DC%2BD1MXksFeitr4%3D 18795898
63. CY Lin IF Tsai YP Ho CT Huang YC Lin CJ Lin, et al. 2007 Endotoxemia contributes to the immune paralysis in patients with cirrhosis J Hepatol 46 816 826 1:CAS:528:DC%2BD2sXjvFamtbw%3D 17328986
64. R Wiest G Garcia-Tsao 2005 Bacterial translocation (BT) in cirrhosis Hepatology 41 422 433 1:CAS:528:DC%2BD2MXisFCku7g%3D 15723320
65. J Such C Munoz P Zapater M Perez-Mateo 2005 Bacterial DNA induces a proinflammatory immune response in patients with decompensated cirrhosis Gut 54 1500 1:STN:280:DC%2BD2Mvpt1Sitw%3D%3D 16162957 author reply 1500
66. J Such R Frances C Munoz P Zapater JA Casellas A Cifuentes, et al. 2002 Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites Hepatology 36 135 141 1:CAS:528:DC%2BD38Xlslyru7g%3D 12085357
67. HA Jarvelainen C Fang M Ingelman-Sundberg KO Lindros 1999 Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines Hepatology 29 1503 1510 1:CAS:528:DyaK1MXjt1Wnu7c%3D 10216135
68. H Prytz J Holst-Christensen B Korner H Liehr 1976 Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis Scand J Gastroenterol 11 857 863 1:STN:280:DyaE2s%2FotVOjsQ%3D%3D 794999
69. RS Lin FY Lee SD Lee YT Tsai HC Lin RH Lu, et al. 1995 Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation J Hepatol 22 165 172 1:STN:280:DyaK2MzhtVOitg%3D%3D 7790704
70. A Nakao S Taki M Yasui Y Kimura T Nonami A Harada, et al. 1994 The fate of intravenously injected endotoxin in normal rats and in rats with liver failure Hepatology 19 1251 1256 1:CAS:528:DyaK2cXltVWmtbc%3D 8175149
71. SC Robson K Jaskiewicz G Engelbrecht D Kahn R Hickman RE Kirsch 1995 Haemostatic and immunological sequelae of portacaval shunt in rats Liver 15 293 299 1:STN:280:DyaK287pt1yrsQ%3D%3D 8609808
72. N Hashimoto H Ohyanagi 2002 Effect of acute portal hypertension on gut mucosa Hepatogastroenterolgy 49 1567 1570
73. A Kaser O Ludwiczek P Waldenberger W Jaschke W Vogel H Tilg 2002 Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting Liver 22 380 387 1:CAS:528:DC%2BD38Xpt12hur4%3D 12390473
74. IA Rajkovic AG Yousif-Kadaru RJ Wyke R Williams 1984 Polymorphonuclear leucocyte locomotion and aggregation in patients with alcoholic liver disease Clin Exp Immunol 58 654 662 1:STN:280:DyaL2M%2FnsFajsQ%3D%3D 6509797 (Pubitemid 15189996)
75. Y Ono T Watanabe K Matsumoto T Ito O Kunii E Goldstein 2004 Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood J Infect Chemother 10 200 207 1:CAS:528:DC%2BD2cXnsVCisLs%3D 15365859
76. L Hoyles J Vulevic 2008 Diet, immunity and functional foods Adv Exp Med Biol 635 79 92 18841705
77. F Ledesma Castano S Echevarria Vierna JL Lozano Polo R Oloriz Rivas C Alvarez Moreno F Pons Romero 1992 Interleukin-1 in alcoholic cirrhosis of the liver: the influence of nutrition Eur J Clin Nutr 46 527 533 1:STN:280:DyaK38zisVWitg%3D%3D 1623857
78. F Gomez P Ruiz AD Schreiber 1994 Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis N Engl J Med 331 1122 1128 1:STN:280:DyaK2M%2FitFGgtA%3D%3D 7935636
79. JC Hurley 1995 Endotoxemia: methods of detection and clinical correlates Clin Microbiol Rev 8 268 292 1:STN:280:DyaK2Mzks1yksA%3D%3D 7621402
80. RS McCuskey R Urbaschek B Urbaschek 1996 The microcirculation during endotoxemia Cardiovasc Res 32 752 763 1:STN:280:DyaK2s%2Fnt1ChtQ%3D%3D 8915193
81. JB Hoek 1999 Endotoxin and alcoholic liver disease: tolerance and susceptibility Hepatology 29 1602 1604 1:STN:280:DyaK1M3jsVWntA%3D%3D 10216149
82. JC Marshall D Foster JL Vincent DJ Cook J Cohen RP Dellinger, et al. 2004 Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study J Infect Dis 190 527 534 1:CAS:528: DC%2BD2cXmvF2ntrc%3D 15243928
83. C Bode V Kugler JC Bode 1987 Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess J Hepatol 4 8 14 1:STN:280: DyaL2s7ps1ajsQ%3D%3D 3571935
84. M Fujimoto M Uemura Y Nakatani S Tsujita K Hoppo T Tamagawa, et al. 2000 Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance Alcohol Clin Exp Res 24 48S 54S 1:CAS:528:DC%2BD3cXjtlyktbw%3D 10803780
85. J Vlachogiannakos AS Saveriadis N Viazis I Theodoropoulos K Foudoulis S Manolakopoulos, et al. 2009 Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis Aliment Pharmacol Ther 29 992 999 1:CAS:528:DC%2BD1MXlsFWltbg%3D 19210289
86. DW Han 2002 Intestinal endotoxemia as a pathogenetic mechanism in liver failure World J Gastroenterol 8 961 965 12439906
87. H Fukui 2005 Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure Alcohol Clin Exp Res 29 172S 179S 1:CAS:528:DC%2BD2MXhtlShtr7N 16344605
88. S Schenker MK Bay 1995 Alcohol and endotoxin: another path to alcoholic liver injury? Alcohol Clin Exp Res 19 1364 1366 1:STN:280:DyaK287hvFCjsw%3D%3D 8561316
89. N Enomoto K Ikejima B Bradford C Rivera H Kono DA Brenner, et al. 1998 Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin Gastroenterology 115 443 451 1:CAS:528:DyaK1cXltl2ns7g%3D 9679050
90. R Baveja S Keller Y Yokoyama N Sonin MG Clemens JX Zhang 2002 LPS-induced imbalanced expression of hepatic vascular stress genes in cirrhosis: possible mechanism of increased susceptibility to endotoxemia Shock 17 316 321 11954834
91. NK Ganguly JG Kingham B Lloyd RS Lloyd CP Price DR Triger, et al. 1978 Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis Lancet 1 1073 1075 1:CAS:528:DyaE1cXlsVCntro%3D 77370
92. RJ Ulevitch AR Johnston DB Weinstein 1981 New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide- high density lipoprotein complex formed in rabbit plasma J Clin Invest 67 827 837 1:CAS:528:DyaL3MXhtFKntrY%3D 7204557
93. P Fraunberger G Pilz P Cremer K Werdan AK Walli 1998 Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock Shock 10 359 363 1:STN:280:DyaK1M%2FlsVertQ%3D%3D 9840652
94. S Zambon R Orlando G Sartore A Bassi E Manzato G Crepaldi 1995 The lipoprotein composition of plasma and ascitic fluid in liver cirrhosis Eur J Clin Invest 25 143 148 1:STN:280:DyaK2MzgtVynsw%3D%3D 7781659
95. A Galbois D Thabut KA Tazi M Rudler MS Mohammadi D Bonnefont-Rousselot, et al. 2009 Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis Hepatology 49 175 184 1:CAS:528:DC%2BD1MXhsFGltLo%3D 19053046
96. H Fukui S Tsujita M Matsumoto M Morimura H Kitano K Kinoshita, et al. 1995 Endotoxin inactivating action of plasma in patients with liver cirrhosis Liver 15 104 109 1:STN:280:DyaK2MzhtFKmtQ%3D%3D 7791538
97. Peters T. All about Albumin: Biochemistry, Genetics, and Medical Applications. Academic Press, San Diego, CA
98. V Arroyo 2002 Review article: Albumin in the treatment of liver diseases - new features of a classical treatment Aliment Pharmacol Ther 16 Suppl 5 1 5 1:CAS:528:DC%2BD3sXlsFyksQ%3D%3D 12423447
99. MR Mc JL Oncley 1958 The specific binding of L-tryptophan to serum albumin J Biol Chem 233 1436 1447
100. PE Ballmer D Walshe MA McNurlan H Watson PW Brunt PJ Garlick 1993 Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification Hepatology 18 292 297 1:STN:280:DyaK3szjvFOhtQ%3D%3D 8340057
101. P Essen MA McNurlan L Gamrin K Hunter G Calder PJ Garlick, et al. 1998 Tissue protein synthesis rates in critically ill patients Crit Care Med 26 92 100 1:STN:280:DyaK1c%2FovVyhtw%3D%3D 9428549
102. R Jalan D Kapoor 2004 Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid Clin Sci (Lond) 106 467 474 1:CAS:528:DC%2BD2cXjsFSmsrs%3D
103. R Ortega P Gines J Uriz A Cardenas B Calahorra D De Las Heras, et al. 2002 Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study Hepatology 36 941 948 1:CAS:528:DC%2BD38XotlGhsLs%3D 12297842
104. P Sort M Navasa V Arroyo X Aldeguer R Planas L Ruiz-del-Arbol, et al. 1999 Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 403 409 1:CAS:528:DyaK1MXltlyltb8%3D 10432325
105. GJ Quinlan GS Martin TW Evans 2005 Albumin: biochemical properties and therapeutic potential Hepatology 41 1211 1219 1:CAS:528:DC%2BD2MXlvVSntb0%3D 15915465
106. K Oettl RE Stauber 2007 Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties Br J Pharmacol 151 580 590 1:CAS:528:DC%2BD2sXntFemsbo%3D 17471184
107. T Hayashi S Era K Kawai H Imai K Nakamura E Onda, et al. 2000 Observation for redox state of human serum and aqueous humor albumin from patients with senile cataract Pathophysiology 6 237 243 1:CAS:528:DC%2BD3cXht1Kmu74%3D
108. WL Hughes HM Dintzis 1964 Crystallization of the mercury dimers of human and bovine mercaptalbumin J Biol Chem 239 845 849 1:CAS:528:DyaF2cXks1OjsA%3D%3D 14154464
109. K Oettl V Stadlbauer F Petter J Greilberger C Putz-Bankuti S Hallstrom, et al. 2008 Oxidative damage of albumin in advanced liver disease Biochim Biophys Acta 1782 469 473 1:CAS:528:DC%2BD1cXnsFOrtrg%3D 18498776
110. G Jurgens M Muller P Garidel MH Koch H Nakakubo A Blume, et al. 2002 Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A J Endotoxin Res 8 115 126 1:CAS:528: DC%2BD38Xlt1eisr8%3D 12028751
111. TL Gioannini D Zhang A Teghanemt JP Weiss 2002 An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation J Biol Chem 277 47818 47825 1:CAS:528:DC%2BD38XptFSqur4%3D 12372833
112. A Broad DE Jones JA Kirby 2006 Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy Curr Med Chem 13 2487 2502 1:CAS:528:DC%2BD28Xot1GjsL8%3D 17017906
113. R Mookerjee V Stadlbauer S Lidder G Wright S Hodges N Davies, et al. 2007 Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome Hepatology 46 831 840 1:CAS:528: DC%2BD2sXhtFWhsrvJ 17680644
114. V Stadlbauer RP Mookerjee GA Wright NA Davies G Jurgens S Hallstrom, et al. 2009 Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis Am J Physiol Gastrointest Liver Physiol 296 G15 G22 1:CAS:528:DC%2BD1MXpsFCmsA%3D%3D 19033535
115. EV Granowitz R Porat JW Mier SF Orencole G Kaplanski EA Lynch, et al. 1993 Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans J Immunol 151 1637 1645 1:CAS:528: DyaK3sXmsVOlt7w%3D 7687636
116. T Manigold U Bocker C Hanck J Gundt P Traber C Antoni, et al. 2003 Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis Eur J Gastroenterol Hepatol 15 275 282 1:CAS:528:DC%2BD3sXhsF2isL8%3D 12610323
117. SM Riordan N Skinner A Nagree H McCallum CJ McIver J Kurtovic, et al. 2003 Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis Hepatology 37 1154 1164 1:CAS:528:DC%2BD3sXktVWnsLc%3D 12717397
118. R Frances P Zapater JM Gonzalez-Navajas C Munoz R Cano R Moreu, et al. 2008 Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis Hepatology 47 978 985 1:CAS:528:DC%2BD1cXktVOhsL0%3D 18306221
119. M Bernardi 2007 Is ceftriaxone better than norfloxacin for prophylaxis of infection in patients with advanced cirrhosis and hemorrhage? Nat Clin Pract Gastroenterol Hepatol 4 190 191 17310231
120. A Albillos L Hera Ad Ade E Reyes J Monserrat L Munoz M Nieto, et al. 2004 Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin J Hepatol 40 624 631 1:CAS:528:DC%2BD2cXitFKhsL0%3D 15030978
121. RN Fedorak 2008 Understanding why probiotic therapies can be effective in treating IBD J Clin Gastroenterol 42 Suppl 3 S111 S115 18806699
122. SM Riordan R Williams 2006 The intestinal flora and bacterial infection in cirrhosis J Hepatol 45 744 757 16979776
123. H An H Xu Y Yu M Zhang R Qi X Yan, et al. 2002 Upregulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways Immunol Lett 81 165 169 1:CAS:528:DC%2BD38Xis1Oqsbc%3D 11947920
124. N Dbouk BM McGuire 2006 Hepatic encephalopathy: a review of its pathophysiology and treatment Curr Treat Options Gastroenterol 9 464 474 17081480
125. Lirussi F, Mastropasqua E, Orando S, Orlando R (2007) Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev CD005165
126. N Rayes D Seehofer S Hansen K Boucsein AR Muller S Serke, et al. 2002 Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients Transplantation 74 123 127 12134110
127. AL D'Souza C Rajkumar J Cooke CJ Bulpitt 2002 Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis BMJ 324 1361 12052801
128. F Cremonini S Di Caro EC Nista F Bartolozzi G Capelli G Gasbarrini, et al. 2002 Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea Aliment Pharmacol Ther 16 1461 1467 1:CAS:528:DC%2BD38XnsVSkt74%3D 12182746
129. LV McFarland 2006 Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease Am J Gastroenterol 101 812 822 16635227
130. W Isakow LE Morrow MH Kollef 2007 Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations Chest 132 286 294 17625089
131. V Stadlbauer RP Mookerjee S Hodges GA Wright NA Davies R Jalan 2008 Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis J Hepatol 48 945 951 1:CAS:528:DC%2BD1cXlvVSksLw%3D 18433921
132. P Tandon K Moncrief K Madsen MC Arrieta RJ Owen VG Bain, et al. 2009 Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study Liver Int 29 1110 1115 19490420
133. H Vilstrup 2003 Cirrhosis and bacterial infections Rom J Gastroenterol 12 297 302 14726975
134. AS Henkel AL Buchman 2006 Nutritional support in patients with chronic liver disease Nat Clin Pract Gastroenterol Hepatol 3 202 209 1:CAS:528:DC%2BD28XksVyitbw%3D 16582962
135. M Charlton 2006 Branched-chain amino acid enriched supplements as therapy for liver disease J Nutr 136 295S 298S 1:CAS:528:DC%2BD28XivFShsg%3D%3D 16365102
136. I Nakamura K Ochiai M Imawari 2004 Phagocytic function of neutrophils of patients with decompensated liver cirrhosis is restored by oral supplementation of branched-chain amino acids Hepatol Res 29 207 211 1:CAS:528: DC%2BD2cXmt1Ontr0%3D 15288012
137. TR Ziegler 1996 Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma JPEN J Parenter Enteral Nutr 20 91 92 1:STN:280:DyaK28zotVamug%3D%3D 8788271
138. PE Marik GP Zaloga 2008 Immunonutrition in critically ill patients: a systematic review and analysis of the literature Intensive Care Med 34 1980 1990 18626628
139. SG Abou-Assi AA Mihas EA Gavis HS Gilles A Haselbush JR Levy, et al. 2006 Safety of an immune-enhancing nutrition supplement in cirrhotic patients with history of encephalopathy JPEN J Parenter Enteral Nutr 30 91 96 1:CAS:528:DC%2BD28XjtlCmuro%3D 16517953
140. S Pazirandeh PR Ling M Ollero F Gordon DL Burns BR Bistrian 2007 Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study JPEN J Parenter Enteral Nutr 31 511 516 1:CAS:528:DC%2BD2sXhtlGru7bK 17947609
141. E Cabre P Rodriguez-Iglesias J Caballeria JC Quer JL Sanchez-Lombrana A Pares, et al. 2000 Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial Hepatology 32 36 42 1:CAS:528:DC%2BD3cXltFWgsrc%3D 10869286
142. MA Alvarez E Cabre V Lorenzo-Zuniga S Montoliu R Planas MA Gassull 2004 Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study Eur J Gastroenterol Hepatol 16 1375 1380 1:CAS:528:DC%2BD2cXhtFeisLvP 15618848
143. V Stadlbauer P Krisper R Aigner B Haditsch A Jung C Lackner, et al. 2006 Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure Crit Care 10 R169 17156425
144. S Sen NA Davies RP Mookerjee LM Cheshire SJ Hodges R Williams, et al. 2004 Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study Liver Transpl 10 1109 1119 15350001
145. K Rifai T Ernst U Kretschmer H Haller MP Manns D Fliser 2006 Removal selectivity of Prometheus: a new extra-corporeal liver support device World J Gastroenterol 12 940 944 16521224
146. V Stadlbauer NA Davies S Sen R Jalan 2008 Artificial liver support systems in the management of complications of cirrhosis Semin Liver Dis 28 96 109 1:CAS:528:DC%2BD1cXjvFCisrw%3D 18293280
147. C Doria IR Marino 2005 Bacteremia using the molecular adsorbent recirculating system in patients bridged to liver transplantation Exp Clin Transplant 3 289 292 15989672
148. H Kanzler FJ Barrat EM Hessel RL Coffman 2007 Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat Med 13 552
149. H Bracht B Hauser Z Ivanyi P Asfar U Ehrmann UB Brueckner, et al. 2009 Efficacy of an extracorporeal endotoxin adsorber system during hyperdynamic porcine endotoxemia Eur Surg Res 43 53 60 1:STN:280:DC%2BD1MvksVSqug%3D%3D 19439972
150. C Fiuza M Salcedo G Clemente JM Tellado 2002 Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease Clin Diagn Lab Immunol 9 433 439 11874890
151. FG Foschi F Trevisani E Loggi M Parazza C Melotti E Bedeschi, et al. 2005 Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophil granulocytes in patients with liver cirrhosis Int Arch Allergy Immunol 137 258 262 15961955